methyl 3,5-bis(benzyloxy)-4-bromobenzoate | 278610-71-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 3,5-bis(benzyloxy)-4-bromobenzoate
• 英文别名: Methyl 4-bromo-3,5-bis(phenylmethoxy)benzoate
• CAS: 278610-71-2
• 化学式: C₂₂H₁₉BrO₄
• 分子量: 427.294
• InChiKey: RQLPCVCAFJWECV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 3,5-bis(benzyloxy)-4-bromobenzoate 在 锂硼氢 作用下， 以 四氢呋喃 为溶剂， 反应 6.0h， 以94%的产率得到[3,5-bis(benzyloxy)-4-bromophenyl]methanol
  参考文献：
  名称：

  A Facile Synthetic Route to a Third-Generation Dendrimer with Generation-Specific Functional Aryl Bromides

  摘要：

  [GRAPHICS]The synthesis of three third-generation dendrimers that selectively carry one aryl bromide functional group in the first, second, or third generation, respectively, is described. These functions, regardless of their location, can be chemically modified by Suzuki cross-coupling chemistry with p-Tert-butylbenzene boronic ester.

  DOI：

  10.1021/ol005972q
• 作为产物：
  描述：

  4-溴-3,5-二羟基苯甲酸 在 硫酸 、 potassium carbonate 作用下， 以 丙酮 为溶剂， 反应 40.0h， 生成 methyl 3,5-bis(benzyloxy)-4-bromobenzoate
  参考文献：
  名称：

  A Facile Synthetic Route to a Third-Generation Dendrimer with Generation-Specific Functional Aryl Bromides

  摘要：

  [GRAPHICS]The synthesis of three third-generation dendrimers that selectively carry one aryl bromide functional group in the first, second, or third generation, respectively, is described. These functions, regardless of their location, can be chemically modified by Suzuki cross-coupling chemistry with p-Tert-butylbenzene boronic ester.

  DOI：

  10.1021/ol005972q

文献信息

• [EN] 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS<br/>[FR] ANALOGUES DE PYRIDAZINE 1,4-DISUBSTITUÉE ET PROCÉDÉS DE TRAITEMENT DE TROUBLES LIÉS À UNE DÉFICIENCE EN SMN
  申请人：NOVARTIS AG

  公开号：WO2014028459A1

  公开（公告）日：2014-02-20

  The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种公式(I)的化合物或其药用可接受的盐；一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药物活性剂的组合物和一种药物组合物。
• THIADIAZOLE ANALOGS THEREOF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED-CONDITIONS
  申请人：AXFORD Jake

  公开号：US20140206661A1

  公开（公告）日：2014-07-24

  The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种公式（X）的化合物或其药用盐；一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药物活性剂的组合物和一种药物组合物。
• 1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS
  申请人：NOVARTIS AG

  公开号：US20170290828A1

  公开（公告）日：2017-10-12

  The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了式I的化合物或其药学上可接受的盐；制备本发明化合物的方法以及其治疗用途。本发明还提供了具有药理活性剂的组合物和制药组合物。
• THIADIAZOLE ANALOGS AND THEIR USE FOR TREATING DISEASES ASSOCIATED WITH A DEFICIENCY OF SMN MOTOR NEURONS
  申请人：Novartis AG

  公开号：EP3736271A1

  公开（公告）日：2020-11-11

  The present invention provides a compound of Formula (X) or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种式（X）化合物或其药学上可接受的盐； 一种制造本发明化合物的方法及其治疗用途。本发明进一步提供了一种药理活性剂的组合物和一种药物组合物。
• 1,4-disubstituted pyridazine analogs there of and methods for treating SMN-deficiency-related conditions
  申请人：NOVARTIS AG

  公开号：US10195196B2

  公开（公告）日：2019-02-05

  The present invention provides a compound of formula I or a pharmaceutically acceptable salt thereof; a method for manufacturing the compounds of the invention, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.

  本发明提供了一种式 I 的化合物或其药学上可接受的盐； 一种制造本发明化合物的方法及其治疗用途。本发明还提供了一种药理活性剂组合和药物组合物。